Three Commitments Approved on One Tuesday

TSMC's board of directors met on 10 November 2026 and approved three equity commitments of up to US$500 million each. One buys common shares in Anthropic, PBC at the per-share price of its IPO. One buys preferred stock in OpenAI Group PBC. The third sets up a company for strategic investments in the semiconductor industry and its ecosystem.

The same meeting approved about US$40.93 billion in capital appropriations for capacity, advanced packaging and R&D, a NT$9 per share dividend for the third quarter and financial statements showing net income of NT$763.06 billion. Next to that, the three stakes are small: up to US$1.5 billion, about 3.7% of the appropriation. Small money, but it changes who holds what.

The Supplier Now Sits on the Customer's Cap Table

A foundry that holds the leading-edge capacity the AI labs depend on is now planning to be a shareholder in two of them. TSMC's resolutions attach no capacity or pricing terms to either stake, and Focus Taiwan quotes market analysts reading the move as optimism about AI development. Anything beyond that is our reading: when the party that allocates scarce chips also owns part of the buyers, the buyers' access stops being a purely commercial matter.

Anthropic is scheduled to list later this month at US$70 to US$78 per share, and TSMC's stake would be bought at that price. OpenAI's is preferred stock, which is paid ahead of common shares in a distribution. The labs gain a long-term supplier with its own money at stake.

What to Ask Before Your Next AI Contract

If you buy AI capacity from a model vendor or a cloud, ask where its chips come from and under what commitments. That matters most for EU businesses, which often buy that capacity from US providers. Vendors tied to a foundry by equity or long contracts may get capacity while others queue, and that shows up in uptime, rate limits and price. Put the answers in the procurement file and keep a second supplier for any workload you cannot pause.